Best of BS Opinion: Green shoots in financial sector, price hike, and more

Kanika Datta sums up the best of BS Opinion articles: from why the public should be consulted in redesigning New Delhi and why the government must not control drug prices.

illustration
Illustration by Ajay Mohanty
Kanika Datta
2 min read Last Updated : Dec 17 2019 | 6:28 AM IST
There’s an unreal quality to politics these days. Discontent over the Citizenship Amendment Act is boiling over into police excesses on campuses. But in jobless, Naxal-infested Jharkhand Amit Shah talks talks to voters about building a sky-touching temple in Ayodhya. It is unclear if anyone in government has absorbed IMF economist Gita Gopinath’s urgent advice on the importance of keeping the fiscal deficit in check. Or Moody’s dismal sub-5 per cent growth projection revision for FY20. Standard & Poor’s recently threatened a downgrade. Have the ratings agencies got it wrong? T T Mohan Ram says here that green shoots in the financial sector are visible but the structural weaknesses are considerable still. In other views, writers mull the future of the markets, the government’s mammoth rebuilding programme for Delhi and drug price controls. Kanika Datta sums up the views.

It's been a tough year for fund managers and many global investors have questioned whether India is the long-term market it was made out to be. 2020 will be the last year to prove otherwise, says Akash Prakash here

The top edit argues for greater transparency in the programme for the makeover of the capital’s central spaces. Read it here

The government’s recent move to raise sharply the price of ceiling on 21 drugs underlines yet again the importance of doing away with drug price controls, says the second edit here 

QUOTE OF THE DAY
 
“These two are not Krishna and Arjuna. They are Shakuni and Duryodhana. Stop attacking #universities! Stop assaulting #students!
 
Tweet by southern actor Siddharth

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Citizenship BillAmit ShahBS OpinionCitizenship ActDrug prices

Next Story